Teva Pharmaceutical Industries Ltd. (TEVA)
37.47
-0.63
(-1.65%)
USD |
NYSE |
Aug 26, 13:11
Teva Pharmaceutical Industries Shareholders Equity (Quarterly) : 7.753B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.753B |
| March 31, 2026 | 8.228B |
| December 31, 2025 | 7.910B |
| September 30, 2025 | 7.250B |
| June 30, 2025 | 6.827B |
| March 31, 2025 | 6.262B |
| December 31, 2024 | 5.373B |
| September 30, 2024 | 6.065B |
| June 30, 2024 | 6.359B |
| March 31, 2024 | 7.278B |
| December 31, 2023 | 7.506B |
| September 30, 2023 | 6.929B |
| June 30, 2023 | 7.052B |
| March 31, 2023 | 7.860B |
| December 31, 2022 | 7.804B |
| September 30, 2022 | 8.767B |
| June 30, 2022 | 9.037B |
| March 31, 2022 | 9.344B |
| December 31, 2021 | 10.28B |
| September 30, 2021 | 10.47B |
| June 30, 2021 | 10.32B |
| March 31, 2021 | 10.00B |
| December 31, 2020 | 10.03B |
| September 30, 2020 | 9.593B |
| June 30, 2020 | 13.85B |
| Date | Value |
|---|---|
| March 31, 2020 | 13.53B |
| December 31, 2019 | 13.97B |
| September 30, 2019 | 13.79B |
| June 30, 2019 | 14.12B |
| March 31, 2019 | 14.73B |
| December 31, 2018 | 14.71B |
| September 30, 2018 | 17.73B |
| June 30, 2018 | 17.94B |
| March 31, 2018 | 18.62B |
| December 31, 2017 | 17.36B |
| September 30, 2017 | 28.67B |
| June 30, 2017 | 27.99B |
| March 31, 2017 | 34.02B |
| December 31, 2016 | 33.34B |
| September 30, 2016 | 35.13B |
| June 30, 2016 | 30.15B |
| March 31, 2016 | 30.44B |
| December 31, 2015 | 29.77B |
| September 30, 2015 | 22.74B |
| June 30, 2015 | 23.04B |
| March 31, 2015 | 22.64B |
| December 31, 2014 | 23.31B |
| September 30, 2014 | 23.63B |
| June 30, 2014 | 23.54B |
| March 31, 2014 | 22.97B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Bristol Myers Squibb Co. | 22.32B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 35.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.86B |
| Total Liabilities (Quarterly) | 32.10B |
| Debt to Equity Ratio | 2.176 |
| Current Ratio | 0.8795 |
| Net Debt Paydown Yield | 0.03% |